A detailed history of Mitchell Sinkler & Starr transactions in Medtronic PLC stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 9,556 shares of MDT stock, worth $774,322. This represents 0.2% of its overall portfolio holdings.

Number of Shares
9,556
Previous 8,890 7.49%
Holding current value
$774,322
Previous $699,000 23.03%
% of portfolio
0.2%
Previous 0.18%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.84 - $91.03 $51,175 - $60,625
666 Added 7.49%
9,556 $860,000
Q2 2024

Aug 07, 2024

BUY
$78.71 - $87.02 $26,053 - $28,803
331 Added 3.87%
8,890 $699,000
Q1 2024

Apr 30, 2024

SELL
$82.84 - $88.09 $231,289 - $245,947
-2,792 Reduced 24.6%
8,559 $745,000
Q4 2023

Feb 12, 2024

BUY
$69.43 - $83.43 $788,099 - $947,013
11,351 New
11,351 $935,000
Q2 2023

Jul 18, 2023

SELL
$79.47 - $91.38 $37,986 - $43,679
-478 Reduced 4.55%
10,021 $882,000
Q1 2023

May 15, 2023

BUY
$76.72 - $87.58 $329,742 - $376,418
4,298 Added 69.31%
10,499 $846,000
Q4 2022

Feb 14, 2023

BUY
$76.18 - $87.74 $30,319 - $34,920
398 Added 6.86%
6,201 $482,000
Q3 2022

Oct 25, 2022

BUY
$80.75 - $95.31 $86,402 - $101,981
1,070 Added 22.61%
5,803 $469,000
Q2 2022

Jul 21, 2022

BUY
$87.4 - $113.09 $7,429 - $9,612
85 Added 1.83%
4,733 $425,000
Q1 2022

Apr 19, 2022

SELL
$100.58 - $112.38 $4,023 - $4,495
-40 Reduced 0.85%
4,648 $516,000
Q3 2021

Oct 12, 2021

SELL
$122.75 - $135.17 $9,820 - $10,813
-80 Reduced 1.68%
4,688 $588,000
Q2 2021

Jul 15, 2021

SELL
$118.19 - $131.5 $2,718 - $3,024
-23 Reduced 0.48%
4,768 $592,000
Q1 2021

Apr 12, 2021

SELL
$111.18 - $119.74 $72,044 - $77,591
-648 Reduced 11.91%
4,791 $566,000
Q4 2020

Feb 09, 2021

BUY
$100.57 - $117.14 $14,079 - $16,399
140 Added 2.64%
5,439 $637,000
Q3 2020

Oct 07, 2020

SELL
$90.13 - $108.78 $28,841 - $34,809
-320 Reduced 5.69%
5,299 $551,000
Q1 2020

Apr 07, 2020

BUY
$72.92 - $121.3 $22,969 - $38,209
315 Added 5.94%
5,619 $507,000
Q4 2019

Jan 09, 2020

BUY
$104.49 - $114.54 $135,837 - $148,902
1,300 Added 32.47%
5,304 $602,000
Q3 2019

Nov 06, 2019

BUY
$98.02 - $111.18 $46,853 - $53,144
478 Added 13.56%
4,004 $435,000
Q2 2019

Jul 17, 2019

SELL
$84.15 - $99.38 $45,441 - $53,665
-540 Reduced 13.28%
3,526 $343,000
Q1 2019

Apr 08, 2019

SELL
$82.45 - $93.79 $21,272 - $24,197
-258 Reduced 5.97%
4,066 $370,000
Q4 2018

Jan 24, 2019

SELL
$85.8 - $99.49 $18,447 - $21,390
-215 Reduced 4.74%
4,324 $393,000
Q3 2018

Oct 04, 2018

SELL
$85.91 - $99.17 $57,473 - $66,344
-669 Reduced 12.85%
4,539 $447,000
Q2 2018

Jul 11, 2018

SELL
$77.48 - $87.83 $30,992 - $35,132
-400 Reduced 7.13%
5,208 $446,000
Q1 2018

Apr 13, 2018

BUY
$76.55 - $87.26 $80,071 - $91,273
1,046 Added 22.93%
5,608 $450,000
Q3 2017

Oct 23, 2017

BUY
$77.71 - $84.6 $354,513 - $385,945
4,562
4,562 $355,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Mitchell Sinkler & Starr Portfolio

Follow Mitchell Sinkler & Starr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.